Rebecca Khan, MD, FACOG, practiced obstetrics and gynecology for 21 years before serving as the director of women’s health for BioReference® Laboratories, LLC. Currently, Khan works in medical affairs at Thermo Fisher Scientific with a focus on placental biomarkers, sFlt-1 and PlGF.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More